Physician profile
Anthony J Brown
NPI 1821250382
$1,500.69
in general payments reported to CMS, 2019-2025
20 companies · $67.16 in 2025
The $67.16 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $473 · 2020: $440 · 2021: $203 · 2022: $192 · 2023: $125 · 2025: $67.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $192.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $295.31 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $266.66 | 2019-2021 | |
| Amgen INC. | $206.95 | 2019-2023 | Prolia, Evenity |
| Pfizer INC. | $138.08 | 2019-2023 | |
| Lilly USA, LLC | $118.00 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $68.72 | 2019-2025 | Gardasil 9, Capvaxive, M-M-R II |
| Abbott Laboratories | $68.30 | 2023-2025 | Freestyle Libre 2, Id Now Instrument |
| Biohaven Pharmaceutical Holding Company LTD. | $52.04 | 2022 | |
| Janssen Pharmaceuticals, INC | $48.95 | 2019-2021 | |
| Daiichi Sankyo INC. | $46.85 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $34.38 | 2022-2023 | |
| Amarin Pharma, INC. | $24.79 | 2019-2020 | |
| Abbvie INC. | $20.37 | 2019 | |
| Sanofi Pasteur INC. | $19.31 | 2020 | |
| Radius Health, INC. | $17.06 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $16.73 | 2022 | |
| Astellas Pharma US INC | $16.54 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.12 | 2019 | |
| Janssen Biotech, INC. | $15.11 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.